Researchers have identified a multitude of molecular markers (e.g., microsatellite instability, HER2, CDX2 and cell cycle regulators) which may exhibit prognostic potential in GC [174,175,176,177,178]. This evidence concerns the gene ERBB2 and gastric cancer.